Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis.

Ceftriaxone, a new third-generation cephalosporin, appears to be promising for the therapy of acute bacterial meningitis. The 90% MBCs of ceftriaxone against 54 recent cerebrospinal fluid isolates of Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae were less than or equal...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Bryan, J P, Rocha, H, da Silva, H R, Taveres, A, Sande, M A, Scheld, W M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180254/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4073858/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.3.361
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!